Hannover Medical School expands its treatment arsenal and includes Integrum’s OPRA[TM] Implant System
Mölndal, Sweden, May 2nd, 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that Hannover Medical School has expanded its treatment arsenal and implemented OPRATM Implant System in clinical use. The first surgeries with the technique have successfully been completed and the hospital will continue to offer the treatment to suitable patients with above-knee, arm, and digit amputations.
Hannover Medical School is the hospital that has tradition with osseointegration in Germany. In October 2022 the new chief of the trauma department - Prof. Stephan Sehmisch- established a new division for Innovations in Amputee Medicine for the best care of amputees. Since December 2021, the hospital has offered Integrum’s OPRA™ Implant System. Two patients, one arm amputee and one leg amputee, have successfully been treated so far.
“Integrum’s OPRA™ Implant System is a much-welcomed complement to our treatment arsenal. With the OPRA™ Implant System, we now have further options to offer our amputees, and I look forward to also being able to treat patients with arm or digit amputations. This innovative implant system will help many of our patients back to an active life,” says Dr. Jennifer Ernst, the surgeon performing the first procedures at Hannover Medical School.
Hannover Medical School is the latest among several new hospitals to offer Integrum’s OPRA™ Implant System in Germany.
“We are delighted to learn about yet another successful clinical implementation of our advanced bone-anchored implants. It is a great acknowledgment of our implant system that Hannover Medical School now chooses to expand their established treatment arsenal and implement our products in clinical use,” comments María López, Integrum’s CEO.
Integrum’s OPRATM Implant System is a bone-anchored system based on osseointegration. As the prostheses are directly attached to the bone, the use of a socket is avoided, leading to fewer complications and better quality of life for the patient.
For more information please contact:
María López, CEO. +46 (0) 70 846 10 69, E-mail: maria.lopez@integrum.se
Dennis Baecklund, CFO. Phone: +46 (0) 72 556 68 69, E-mail: dennis.baecklund@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a US subsidiary in San Francisco, CA. Since 1990, osseointegration, the science behind the OPRA™ Implant System, has been helping individuals with amputations enjoy a dramatically improved quality of life. Thorough surgical experience gained over more than three decades, from more than 500 surgeries, in 14 countries, has led to the development of Integrum’s system for bone-anchored prostheses – a vastly superior alternative to the traditionally used socket prosthesis.